Proteomic Biomarkers of Intrahepatic Cholestasis of Pregnancy

Weijian Zeng,Yanyan Hou,Wei Gu,Zheng Chen

DOI: https://doi.org/10.1007/s43032-023-01437-z

2024-01-06

Reproductive Sciences

Abstract:Intrahepatic cholestasis of pregnancy (ICP) is a pregnancy-specific liver disease, which can lead to adverse fetal outcomes, including preterm labor and intrauterine death. The pathogenesis of ICP is still unclear. We hypothesized that pathological index leads to abnormal placenta changes in ICP. Investigation of these differences in protein expression in parallel profiling is essential to understand the comprehensive pathophysiological mechanism underlying ICP. The present study screened differentially expressed proteins (DEPs) as novel diagnostic markers for ICP. Proteomic profiles of placental tissues from 32 ICP patients and 24 healthy volunteers (controls) were analyzed. Our founding was valid by following western blotting and immunohistochemistry staining, respectively. The association of the key protein expression with clinicopathological features of ICP was further analyzed. A total of 178 DEPs were identified between the ICP and control groups. Functional enrichment analysis showed these proteins were significantly enriched in the PPAR singling pathway by KEGG and PPARα/RXRα activation by IPA. Apolipoprotein A2 (APOA2) was the only upregulated protein, which uniquely identified in ICP groups and related to both pathways. Validation of western blotting and immunohistochemical staining analysis showed significantly higher APOA2 expression in the ICP group than in the control group. Furthermore, the expression of APOA2 is associated with clinicopathological features in ICP groups. Receiver operating characteristic (ROC) curve analyses showed that the AUC of APOA2 was 0.8984 (95% confidence interval (CI): 0.772–1.000). This study has identified up-regulated APOA2 associated with PPAR singling pathway and PPARα/RXRα activation in ICP. Thus, APOA2 may be involved in ICP pathogenesis, serving as a novel biomarker for its diagnosis.

obstetrics & gynecology,reproductive biology

What problem does this paper attempt to address?

The problem this paper attempts to address is: the pathogenesis of Intrahepatic Cholestasis of Pregnancy (ICP) remains unclear, and there is currently a lack of effective diagnostic markers. Therefore, the researchers hypothesize that pathological indices of ICP will lead to abnormal changes in the placenta, and through proteomics analysis, they aim to screen for differentially expressed proteins (DEPs) to identify new diagnostic markers for ICP.

Specifically, the researchers hope to address this issue through the following points:

1. **Screening for Differentially Expressed Proteins**: Using proteomics technology, compare the protein expression profiles in placental tissues of ICP patients and healthy controls to screen for differentially expressed proteins.

2. **Validation of Key Protein Expression**: Validate the expression of key proteins (such as APOA2) in ICP patients through Western Blotting and immunohistochemical staining.

3. **Analysis of the Relationship Between Key Proteins and Clinical Pathological Features**: Investigate the relationship between the expression of key proteins (such as APOA2) and the clinical pathological features of ICP patients.

4. **Evaluation of the Potential of Key Proteins as Diagnostic Markers**: Assess the potential of key proteins (such as APOA2) as diagnostic markers for ICP through Receiver Operating Characteristic (ROC) analysis.

In summary, this study aims to reveal the pathogenesis of ICP through proteomics methods and discover potential diagnostic markers, thereby providing new insights for the early diagnosis and treatment of ICP.